Innate Immunity Hemorrhagic fever viruses
Innate Immunity Hemorrhagic fever viruses
批准号:
7669766
负责人:
Robert William Finberg
金额:
$43.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-03-25 至 2014-02-28
关键词:
AffectAgonistArenavirusCD14 geneCellsCessation of lifeContainmentCytoplasmic ReceptorsDevelopmentDiseaseDoctor of MedicineEbola virusFilovirusFrankfurt-Marburg Syndrome VirusGene ExpressionGenerationsGenesHost DefenseHumanIRF1 geneImmuneImmune responseImmune systemImmunityIn VitroInfectionInflammationInflammatoryInflammatory Response PathwayInterferon Type IInterferonsKnockout MiceLeadLymphocytic choriomeningitis virusMammalsMediatingMolecularMorbidity - disease rateMusNatural ImmunityNew EnglandPathogenesisPathway AnalysisPathway interactionsPatternPharmaceutical PreparationsPlasmidsPreclinical Drug EvaluationProductionProteinsRNA HelicaseRNA SequencesRegulationResearch Project GrantsRoleSatellite VirusesScreening procedureSeriesSigns and SymptomsSpecificityStructureTLR2 geneTLR6 geneTherapeuticToll-like receptorsViralViral GenesViral Hemorrhagic FeversVirusVirus Diseasesacquired immunityanalogbasebiodefensecell typecytokinedrug productionhemorrhagic fever virusin vivomortalitymouse modelnovel strategiesnovel vaccinespathogenpreventreceptorresearch studyresponsesmall moleculetime useviral RNA
中文摘要
点击翻译按钮获取中文摘要
英文摘要
NERCE Project 17: Innate immunity hemorrhagic fever viruses, Robert W. Finberg, M.D., UMass
The innate immune response to hemorrhagic fever viruses determines the early morbidity and mortality
associated with these illnesses. This is a consequence of both induction of host inflammatory cytokines by
the virus, as well as the initial host defense against the virus which includes the production of type 1
interferons (IFN) that prevent viruses from replicating. Our initial series of experiments defined the Toll Like
Receptor (TLR) responses to hemorrhagic fever viruses, focusing on Lymphocytic Choriomeningitis Virus
(LCMV) as a prototypic arenavirus. By using human cells transfected with CD14 and TLR2 and knockout
mice, we were able to demonstrate that the LCMV specific inflammatory cytokine response is mediated
through TLR2, TLR6, and CD14. Screening for small molecules that inhibited LCMV-mediated activation of
NFkB, defined a subset of compounds that may be suitable for preventing TLR2 mediated viral disease by
blocking the induction of inflammatory cytokines ("cytokine storm") associated with many lethal viral
infections.
Our studies of the responses of mouse and human cells to the arenavirus LCMV, and two filoviruses that
cause hemorrhagic fever, namely Ebola and Marburg, reveal that these viruses cause a rapid induction of
inflammatory cytokines in host cells. We plan to use the compounds we have identified as a result of our
screen, in human cells and in mouse models challenged with different hemorrhagic fever to define the
mechanisms of action of these small molecules and determine if they can prevent the "cytokine storm". Initial
virus containment in mammals is dependent upon the induction of type 1 IFN, which is commonly mediated
through cytoplasmic RNA helicases termed RIG-l-like receptors. In this project we will define the genes and
pathways involved in the induction of IFN by hemorrhagic fever viruses and search for small molecules that
might augment that response. In addition we will investigate host genes directly or indirectly modulated by
infection with these viruses and the effects of the small molecules obtained through our screens on
expression of these genes
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
International Immunocompromised Host Society's 19th International Symposium on Infections in the Immunocompromised Host
-
批准号:9260163
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2016
-
负责人:Robert William Finberg
-
依托单位:
18th International Symposium on Infections in the Immunocompromised Host
-
批准号:8720337
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2014
-
负责人:Robert William Finberg
-
依托单位:
17th International Symposium on Infections in the Immunocompromised Host
-
批准号:8330069
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2012
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity Hemorrhagic fever viruses
-
批准号:8233435
-
项目类别:
-
资助金额:$46.31万
-
财政年份:2011
-
负责人:Robert William Finberg
-
依托单位:
Toll2011 Meeting, Decoding Innate Immunity
-
批准号:8130053
-
项目类别:
-
资助金额:$1.2万
-
财政年份:2011
-
负责人:Robert William Finberg
-
依托单位:
16th Symposium on Infections in the Immunocompromised Host
-
批准号:7994945
-
项目类别:
-
资助金额:$0.43万
-
财政年份:2010
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and Herpes Simplex Pathogensis
-
批准号:7877330
-
项目类别:
-
资助金额:$2.07万
-
财政年份:2009
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and Herpes Simplex Infection
-
批准号:7914345
-
项目类别:
-
资助金额:$182.82万
-
财政年份:2009
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and Herpes Simplex Infection
-
批准号:7695247
-
项目类别:
-
资助金额:$185.64万
-
财政年份:2009
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity & Hemorrhagic Fever Viruses
-
批准号:7645348
-
项目类别:
-
资助金额:$68.16万
-
财政年份:2008
-
负责人:Robert William Finberg
-
依托单位:
Pathogenesis of myocarditis
-
批准号:7229933
-
项目类别:
-
资助金额:$19.72万
-
财政年份:2006
-
负责人:Robert William Finberg
-
依托单位:
Pathogenesis of myocarditis
-
批准号:7030183
-
项目类别:
-
资助金额:$24.34万
-
财政年份:2006
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and Herpes Simplex Pathogenesis
-
批准号:7389553
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2005
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and Herpes Simplex Pathogenesis
-
批准号:7578327
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2005
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and Herpes Simplex Pathogenesis
-
批准号:7190470
-
项目类别:
-
资助金额:$31.11万
-
财政年份:2005
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and Herpes Simplex Pathogensis
-
批准号:7025825
-
项目类别:
-
资助金额:$32.02万
-
财政年份:2005
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and Herpes Simplex Pathogenesis
-
批准号:6903196
-
项目类别:
-
资助金额:$35.85万
-
财政年份:2005
-
负责人:Robert William Finberg
-
依托单位:
Cellular Immunity to Category A-C Viruses in Humans
-
批准号:8243671
-
项目类别:
-
资助金额:$314.38万
-
财政年份:2003
-
负责人:Robert William Finberg
-
依托单位:
Cellular Immunity to Category A-C Viruses in Humans
-
批准号:8452136
-
项目类别:
-
资助金额:$295.52万
-
财政年份:2003
-
负责人:Robert William Finberg
-
依托单位:
Innate Immunity and LCMV
-
批准号:6711613
-
项目类别:
-
资助金额:$35.66万
-
财政年份:2003
-
负责人:Robert William Finberg
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: